Wellstar International, Inc. Announces the Submission of the Results of the Study for Publication of the Duke University Study

Wellstar International Inc. (OTCBB:WLSI) has announced the manuscript of the successful results from the completed study at Duke University has been submitted for publishing to the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL on Monday, January 18, 2010. Trillennium Medical Imaging (TMI), a wholly owned subsidiary of Wellstar International Inc., is satisfied with the results of this study, of which the details will be released upon publication, which unfortunately due to protocol will not be for several months. After their acceptance of the manuscript we will comment further.

The study was designed to determine that long-wave infrared imaging can be used to identify skin temperature changes associated with underlying tissue changes. We wanted to determine if the use of Long Wave infrared imaging will be more effective than the Braden Score in predicting nosocomial pressure ulcers. The Braden Scale is the current Gold Standard used within the industry for determining the possibility of an existing pressure ulcer, and our goal is to replace the Braden Scale with the TMI System as the Gold Standard within the industry.

With the results being submitted for publication of the study, our next stage in development will focus on running Beta Tests within the marketplace subject to obtaining the needed capital. We cannot provide any guarantee that we will be able to successfully raise capital, or if we do raise capital, that it will be on acceptable terms. These two Beta Tests will run simultaneously and allow for Wellstar to work out the installation and execution process of our system. It is anticipated that the Beta Test will be for a period of between 90 and 120 days after commencement.

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.